Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0982
Bid: 0.098
Ask: 0.1045
Change: -0.0023 (-2.29%)
Spread: 0.0065 (6.633%)
Open: 0.10
High: 0.10
Low: 0.0982
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Share Options to Directors

30 Aug 2018 07:00

RNS Number : 1932Z
Versarien PLC
30 August 2018
 

Versarien plc

("Versarien" or the "Company")

Award of Share Options to Directors

Versarien plc (AIM: VRS), the advanced materials engineering group, announces that the Board has issued options over an aggregate of 5,339,232 ordinary shares of 1 pence each in the Company ("Share Options"), as approved by the Company's Remuneration Committee, as detailed below. The Share Options represent 3.6 per cent of the Company's current issued share capital.

Neill Ricketts, Chief Executive Officer, and Christopher Leigh, Chief Financial Officer, have each been awarded 2,669,616 Share Options under the Company's Employee Share Option Plan 2013. The Share Options will vest and may be exercised on the following basis:

· One-third on or after 30 August 2021 ("Vesting Period 1");

· One-third on or after 30 August 2022 ("Vesting Period 2"); and

· One-third on or after 30 August 2023 ("Vesting Period 3").

The exercise price for the Share Options is 152p.

The Share Options may be exercised provided that the Company's average share price in the 30 days prior to exercise is not less than 183p prior to Vesting Period 1 exercise, 213p prior to Vesting Period 2 exercise and 244p prior to Vesting Period 3 exercise.

Following the grant of the Share Options, Neill Rickets is interested in 15,250,000 Versarien ordinary shares, representing 10.26 per cent of the Company's issued share capital and options over a further 6,346,991 ordinary shares. Christopher Leigh is interested in 315,000 Versarien ordinary shares, representing 0.21 per cent of the Company's issued share capital and options over a further 6,346,991 ordinary shares.

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

01242 269 122

Arden Partners (Nominated Adviser and Broker)

Chris Hardie

Dan Gee-Summons

020 7614 5900

IFC Advisory (Financial PR and IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

020 3934 6630

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neill Ricketts

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

183 pence per share

889,872

213 pence per share

889,872

244 pence per share

889,872

 

d)

Aggregated information

- Aggregated volume

- Price

 

2,669,616

n/a

e)

Date of the transaction

30 August 2018

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher Leigh

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

183 pence per share

889,872

213 pence per share

889,872

244 pence per share

889,872

 

d)

Aggregated information

- Aggregated volume

- Price

 

2,669,616

n/a

e)

Date of the transaction

30 August 2018

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPGUCPRUPRGQB
Date   Source Headline
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.